Fuse Medical, Inc. Financial Summary

Quick Answer

Fuse Medical, Inc. reported Total Revenue of $18.64 million for fiscal year 2022.

Fuse Medical, Inc. — Key Financials by Year

Metric 2022 2021 2020 2019 2018 2017
Total Revenue $18.64M
-8.7%
$20.41M
-4.6%
$21.40M
-6.6%
$22.90M
-13.1%
$26.34M
-0.2%
$26.41M
+2.9%
Revenue (ASC 606) $18.64M
-8.7%
$20.41M
-4.6%
$21.40M
-6.6%
$22.90M
-13.1%
$26.34M
Net Income $3.10M
+295.1%
-$1.59M
-10.8%
-$1.43M
+56.8%
-$3.32M
-183.8%
$3.96M
+465.6%
$699.7K
-76.8%
Diluted EPS $0.04
+300.0%
-$0.02
+0.0%
-$0.02
+60.0%
-$0.05
-200.0%
$0.05
+25.0%
$0.04
-87.9%
Total Assets $19.76M
+8.0%
$18.30M
+5.1%
$17.42M
-5.2%
$18.38M
-17.1%
$22.17M
+15.2%
$19.25M
-1.7%
Cash and Equivalents $147.9K
-73.3%
$553.2K
-53.4%
$1.19M
+8.0%
$1.10M
+30.2%
$844.3K
+4.9%
$804.7K
+3.4%
Stockholders Equity -$310.9K
+90.9%
-$3.43M
-62.4%
-$2.11M
-72.9%
-$1.22M
-183.3%
$1.47M
+118.4%
-$7.98M
-175.3%
Operating Income -$815.1K
+62.9%
-$2.20M
-113.6%
-$1.03M
+76.4%
-$4.35M
-122.1%
-$1.96M
-328.0%
$858.9K
-72.9%
Gross Profit $11.54M
-3.3%
$11.94M
-6.0%
$12.70M
+14.1%
$11.14M
-14.3%
$12.99M
+9.8%
$11.82M
-17.9%
Shares Outstanding 73.90M
+1.4%
72.90M
-0.3%
73.12M
+0.0%
73.12M
-2.0%
74.60M
+13.2%
65.89M
+314.6%

Most Recent Quarter

Metric Quarter Ending Value YoY QoQ
Total Revenue June 30, 2023 $5.00M +7.0% +25.4%
Revenue (ASC 606) June 30, 2023 $5.00M +7.0% +25.4%
Net Income June 30, 2023 $307.6K +195.2% +234.7%
Diluted EPS March 31, 2023 $0.00 +100.0% +100.0%
Total Assets June 30, 2023 $19.32M +1.4% +4.8%
Cash and Equivalents June 30, 2023 $253.4K +71.4%
Stockholders Equity June 30, 2023 -$231.6K +94.5% +57.0%
Operating Income June 30, 2023 $368.9K +814.6% +322.8%
Gross Profit June 30, 2023 $3.47M +17.8% +23.2%
Shares Outstanding June 30, 2023 73.90M +1.4% +0.0%
  • Fuse Medical, Inc. reported Total Revenue of $18.64 million for fiscal year 2022.
  • Fuse Medical, Inc. showed a decrease of -8.7% in Total Revenue compared to the prior fiscal year.
  • Fuse Medical, Inc. reported Revenue (ASC 606) of $18.64 million for fiscal year 2022.
  • Fuse Medical, Inc. showed a decrease of -8.7% in Revenue (ASC 606) compared to the prior fiscal year.
  • Fuse Medical, Inc. reported Net Income of $3.10 million for fiscal year 2022.
  • Fuse Medical, Inc. showed an increase of +295.1% in Net Income compared to the prior fiscal year.
  • Fuse Medical, Inc. reported Diluted EPS of $0.04 per share for fiscal year 2022.
  • Fuse Medical, Inc. showed an increase of +300.0% in Diluted EPS compared to the prior fiscal year.
  • Fuse Medical, Inc. reported Total Assets of $19.76 million for fiscal year 2022.
  • Fuse Medical, Inc. showed an increase of +8.0% in Total Assets compared to the prior fiscal year.
  • Fuse Medical, Inc. reported Cash and Equivalents of $147.9 thousand for fiscal year 2022.
  • Fuse Medical, Inc. showed a decrease of -73.3% in Cash and Equivalents compared to the prior fiscal year.
  • Fuse Medical, Inc. reported Stockholders Equity of -$310.9 thousand for fiscal year 2022.
  • Fuse Medical, Inc. showed an increase of +90.9% in Stockholders Equity compared to the prior fiscal year.
  • Fuse Medical, Inc. reported Operating Income of -$815.1 thousand for fiscal year 2022.
  • Fuse Medical, Inc. showed an increase of +62.9% in Operating Income compared to the prior fiscal year.
  • Fuse Medical, Inc. reported Gross Profit of $11.54 million for fiscal year 2022.
  • Fuse Medical, Inc. showed a decrease of -3.3% in Gross Profit compared to the prior fiscal year.
  • Fuse Medical, Inc. reported Shares Outstanding of 73.90 million shares for fiscal year 2022.
  • Fuse Medical, Inc. showed an increase of +1.4% in Shares Outstanding compared to the prior fiscal year.
  • All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.

Last verified:

Leave a Comment